We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,357
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLR
1676
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $2.49M | ﹤0.01% |
72,621
+740
| +1% | +$23K |
|
|
ALLK
1677
DELISTED
Allakos
ALLK
| $2.48M | ﹤0.01% |
26,047
+1,183
| +5% | +$104K |
|
1678
Marcus Corp
MCS
$948M
| $2.48M | ﹤0.01% |
78,194
+5,157
| +7% | +$174K |
|
|
CVA
1679
DELISTED
Covanta Holding Corporation
CVA
| $2.48M | ﹤0.01% |
166,918
+1,855
| +1% | +$28.3K |
|
1680
Anika Therapeutics
ANIK
$268M
| $2.47M | ﹤0.01% |
47,639
+2,756
| +6% | +$160K |
|
1681
Veeco
VECO
$3.3B
| $2.46M | ﹤0.01% |
167,640
+9,139
| +6% | +$124K |
|
1682
ICF International
ICFI
$1.54B
| $2.46M | ﹤0.01% |
26,828
+471
| +2% | +$40.5K |
|
|
CXP
1683
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $2.46M | ﹤0.01% |
117,524
+8,093
| +7% | +$166K |
|
|
EBIX
1684
DELISTED
Ebix Inc
EBIX
| $2.45M | ﹤0.01% |
73,270
+4,213
| +6% | +$156K |
|
1685
Atkore
ATKR
$3.17B
| $2.44M | ﹤0.01% |
60,436
+2,822
| +5% | +$104K |
|
|
DOOR
1686
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $2.44M | ﹤0.01% |
33,791
+476
| +1% | +$31.3K |
|
1687
First Busey Corp
BUSE
$2.61B
| $2.43M | ﹤0.01% |
88,256
+2,615
| +3% | +$69K |
|
1688
BancFirst
BANF
$3.83B
| $2.42M | ﹤0.01% |
38,798
+398
| +1% | +$23.4K |
|
1689
National Beverage
FIZZ
$3B
| $2.42M | ﹤0.01% |
94,828
+5,344
| +6% | +$128K |
|
|
AVYA
1690
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $2.42M | ﹤0.01% |
178,965
+1,944
| +1% | +$23.9K |
|
|
RTL
1691
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $2.42M | ﹤0.01% |
182,149
+12,026
| +7% | +$172K |
|
|
AEGN
1692
DELISTED
Aegion Corp
AEGN
| $2.41M | ﹤0.01% |
107,933
+4,245
| +4% | +$91.8K |
|
1693
Ichor Holdings
ICHR
$2.51B
| $2.41M | ﹤0.01% |
72,541
+3,723
| +5% | +$111K |
|
1694
RE/MAX Holdings
RMAX
$216M
| $2.41M | ﹤0.01% |
62,681
+4,237
| +7% | +$152K |
|
1695
ArcBest
ARCB
$3.11B
| $2.41M | ﹤0.01% |
87,162
+4,039
| +5% | +$117K |
|
1696
TriMas Corp
TRS
$1.48B
| $2.4M | ﹤0.01% |
76,327
+902
| +1% | +$27.8K |
|
1697
Artisan Partners
APAM
$3.05B
| $2.4M | ﹤0.01% |
74,138
+2,368
| +3% | +$68.4K |
|
1698
Century Communities
CCS
$1.97B
| $2.4M | ﹤0.01% |
87,619
+5,421
| +7% | +$159K |
|
|
MNR
1699
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $2.39M | ﹤0.01% |
165,121
+9,133
| +6% | +$135K |
|
1700
Clearway Energy Class C
CWEN
$5.17B
| $2.39M | ﹤0.01% |
119,730
+3,900
| +3% | +$75.5K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.